Summary. The useful range of blood glucose measurements with Dextrostix can be extended by varying the incubation time and making appropriate corrections to the observed values.
Dextrostix reagent strips use a glucose oxidase enzymatic reaction which is incomplete after 3 min. The measured blood glucose concentration rises progressively the longer the blood is allowed to remain in contact with the reagent pad. The aim of this study was to determine how this aspect of Dextrostix could extend the range of these test strips.
Methods
Thirty blood samples were collected from non-diabetic patients, diabetic patients and patients undergoing an insulin tolerance test to obtain a wide range of glucose concentrations. Samples were collected into lithium heparin tubes and maintained at 34-37 ~ in a water bath. Drops of blood from each sample were placed on the Dextrostix reagent pad and left in contact for exactly 15, 30, 45, 60, 90, 120 and In addition, a further ten samples were left in contact with the reagent at 30, 35, 60 and 65 s to determine the effect of a small timing error (5 s). The strips were then read on an Eyetone (Ames Division, Miles Laboratories, Slough, Bucks, UK) and a Glucochek meter (Medistron, Crawley, Sussex, UK). Two additional samples were incubated with glucose to produce very high concentrations (33 and 39 mmol/1, respectively).
Results
Blood glucose readings on the Eyetone and Glucochek meters after the various time intervals are shown in Figure 1 (range at 60s 0.6-/8.5 mmol/1). Increasing the contact time of the blood on the reagent strip produced a steadily progressive rise in the measured blood glucose concentration as would be expected from the nature of the glucose-oxidase reaction. There was a slight difference between the values obtained using the Eyetone and Glucochek meters but this was not statistically significant.
In Figure 2 , for each blood sample the meter reading at 15sx4, 30sx2, 60s, 90sx0.67, 120sx0.5 and 180 s x 0.33 is plotted and then each point for a given blood sample is joined by a straight line. If the technique is to give accurate results then for each sample a straight horizontal line should result which passes through the 'true' 60 s value. This was generally the case except for the 15 s x 4value.
The Eyetone meter is calibrated to read as low as 0.6 mmol but its accuracy at this level is often questioned. We found that leaving blood in contact with the reagent pad for 120 or 180 s and dividing the value obtained by 2 or 3 respectively gave a confirmatory (and probably more accurate) measure of the degree of hypoglycaemia. When the blood glucose was very high (> 22 mmol/1), a reading could not be obtained on the Eyetone without shortening the incubation time (e.g: 30 s value x 2) when a more precise measurement was possible. Two blood samples with glucose concentrations of 33 and 39 mmol/1 were analysed using this technique. The 30 s value x 2 for the 33 mmol/1 blood was 34 mmol/1 (Eyetone) and 34.4 mmol/l (Glucochek) and for the 39mmol/t sample the results were 36 mmol/1 (Eyetone) and 37 mmol/1 (Glucochek). In a separate set of experiments we found that with incubation times of 30 and 60 s the effect of a small timing error (5 s) was so small as to be of no clinical significance.
Discussion
Our results indicate that it is not always necessary to read Dextrostix after a contact time of 60 s and we have shown that by altering this incubation time the useful range of Dextrostix may be extended. This may not be relevant in the context of home blood glucose monitoring by diabetic patients, but clearly is for doctors treating hyperglycaemic or hypoglycaemic emergencies.
